Core Laboratories
CLB
197 hedge funds and large institutions have $868M invested in Core Laboratories in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 46 closing their positions.
82% more capital invested
Capital invested by funds: $476M → $868M (+$391M)
69% more call options, than puts
Call options by funds: $5.53M | Put options by funds: $3.27M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 207 → 197 (-10)
7.81% less ownership
Funds ownership: 103.62% → 95.81% (-7.8%)
13% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 72
22% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$37.4M |
| 2 |
BlackRock
New York
|
+$31.7M |
| 3 |
AC
AKO Capital
London,
United Kingdom
|
+$23.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$21.4M |
| 5 |
EARNEST Partners
Atlanta,
Georgia
|
+$12.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VanEck Associates
New York
|
-$82.3M |
| 2 |
Goldman Sachs
New York
|
-$28M |
| 3 |
Bank of New York Mellon
New York
|
-$17.8M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15.4M |
| 5 |
Morgan Stanley
New York
|
-$13.4M |
CLB Hedge Fund Activity: Q2 2020 in Review
197 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2020, worth a combined $868M — up 82% from $476M a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of CLB and 36 opened new positions — a net loss of 10 holders — while 72 trimmed existing stakes and 63 added.
The largest buyer was Ariel Investments, opening a new position worth an estimated $37.4M. The largest seller was VanEck Associates, cutting an estimated $82.3M.
- 197 institutional investors held Core Laboratories (CLB) as of Q2 2020, down from 207 in Q1 2020.
- Funds reported $868M of Core Laboratories stock for Q2 2020, up 82% quarter-over-quarter.
- 36 funds opened new Core Laboratories positions in Q2 2020 and 46 closed out, a net change of -10 holders.
- The largest Core Laboratories buyer in Q2 2020 was Ariel Investments, an estimated $37.4M added.
- The largest Core Laboratories seller in Q2 2020 was VanEck Associates, an estimated $82.3M sold.
Based on aggregated 13F filings for Q2 2020.